| 000 | 01832 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515090331.0 | ||
| 264 | 0 | _c20071107 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1536-4828 | ||
| 024 | 7 |
_a10.1097/MPA.0b013e318064678a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Bao-Quan | |
| 245 | 0 | 0 |
_aEthyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. _h[electronic resource] |
| 260 |
_bPancreas _cOct 2007 |
||
| 300 |
_a256-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aHMGB1 Protein |
| 650 | 0 | 4 |
_aHigh Mobility Group Proteins _xblood |
| 650 | 0 | 4 |
_aInterleukin-1beta _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPancreatitis _xblood |
| 650 | 0 | 4 |
_aPyruvates _xadministration & dosage |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRepressor Proteins _xblood |
| 650 | 0 | 4 |
_aTaurodeoxycholic Acid _xtoxicity |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aLiu, Chun-Tao | |
| 700 | 1 | _aLi, Wen-Jie | |
| 700 | 1 | _aFan, Wei | |
| 700 | 1 | _aZhong, Ning | |
| 700 | 1 | _aZhang, Yan | |
| 700 | 1 | _aJia, Xiao-Qing | |
| 700 | 1 | _aZhang, Shang-Zhong | |
| 773 | 0 |
_tPancreas _gvol. 35 _gno. 3 _gp. 256-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MPA.0b013e318064678a _zAvailable from publisher's website |
| 999 |
_c17418338 _d17418338 |
||